ANGIOCRINE BIOSCIENCE
Angiocrine Bioscience has developed a cellular platform for amplifying stem and progenitor cells, in both human and mouse models, by recapitulating the proliferative stimulation of the in vivo vascular niche in vitro. The expansion capacity is on an unprecedented scale when compared to any other competing technology, and it is achieved without the requirement for costly media additives. This process can meet the needs of a broad range of therapeutic, diagnostic, and research applications. We look forward to the expansive application of this technology to help fulfill the promise of tissue-specific engineering and organ-regeneration.
ANGIOCRINE BIOSCIENCE
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2012-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.angiocrinebioscience.com
Total Employee:
1+
Status:
Active
Contact:
530-745-9560
Email Addresses:
[email protected]
Total Funding:
62.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Wordpress Plugins Nginx
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Official Site Inspections
http://www.angiocrinebioscience.com
- Host name: 201.34.196.104.bc.googleusercontent.com
- IP address: 104.196.34.201
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
